Clinical trials
Phase 2 Cerebral Palsy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Shirley Ryan AbilityLab | 2 |
| University of Oklahoma | 2 |
| University of Southern California | 2 |
| Agency for Healthcare Research and Quality (AHRQ) | 1 |
| Children's Hospital Los Angeles | 1 |
| Eli Lilly and Company | 1 |
| Joanne Kurtzberg, MD | 1 |
| Johns Hopkins University | 1 |
| National Center for Complementary and Integrative Health (NCCIH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebral Palsy | 19 |
| Brain Injuries | 3 |
| Muscle Spasticity | 2 |
| Paresis | 2 |
| Arthrogryposis | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Dystonia | 1 |
| Muscular Atrophy, Spinal | 1 |
| Musculoskeletal Diseases | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.